Literature DB >> 12175454

Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.

Helen Rosengarten1, David Quartermain.   

Abstract

The typical antipsychotic haloperidol and atypical antipsychotics olanzapine, quetiapine and risperidone were administered to pregnant Sprague-Dawley dams in the drinking water from Days 8 to 18 of gestation. When the offspring reached adulthood (2 months), spatial learning and short-term retention were examined using the radial arm maze. Results showed that prenatal administration of haloperidol, risperidone and quetiapine impaired learning but only haloperidol and risperidone disrupted short-term retention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175454     DOI: 10.1016/s0091-3057(02)00727-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

Review 1.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

2.  Prenatal antipsychotic exposure and neuromotor performance during infancy.

Authors:  Katrina C Johnson; Jamie L LaPrairie; Patricia A Brennan; Zachary N Stowe; D Jeffrey Newport
Journal:  Arch Gen Psychiatry       Date:  2012-08

3.  Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul Horn; Kevin Stanford; Stefanie L Bronson; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2011-03-25       Impact factor: 4.791

4.  Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul Horn; Rabindra Tambyraja; Molly Grainger; Stefanie L Bronson; Robert K McNamara
Journal:  Physiol Behav       Date:  2012-02-09

Review 5.  Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?

Authors:  Susan L Andersen; Carryl P Navalta
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

6.  Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.

Authors:  S J Kanes; J Tokarczyk; S J Siegel; W Bilker; T Abel; M P Kelly
Journal:  Neuroscience       Date:  2006-11-01       Impact factor: 3.590

Review 7.  Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Authors:  Elizabeth Brunner; Deborah M Falk; Meghan Jones; Debashish K Dey; Chetan Chinmaya Shatapathy
Journal:  BMC Pharmacol Toxicol       Date:  2013-08-01       Impact factor: 2.483

Review 8.  Mood stabilizers in pregnancy and lactation.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759

9.  Teratogenic effects of coadministration of fluoxetine and olanzapine on rat fetuses.

Authors:  Azam Bakhtiarian; Nasrin Takzare; Mehdi Sheykhi; Narges Sistany; Farahnaz Jazaeri; Mario Giorgi; Vahid Nikoui
Journal:  Adv Pharmacol Sci       Date:  2014-01-15

10.  Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.

Authors:  Michael Aschner; Sandra Ceccatelli; Mardas Daneshian; Ellen Fritsche; Nina Hasiwa; Thomas Hartung; Helena T Hogberg; Marcel Leist; Abby Li; William R Mundi; Stephanie Padilla; Aldert H Piersma; Anna Bal-Price; Andrea Seiler; Remco H Westerink; Bastian Zimmer; Pamela J Lein
Journal:  ALTEX       Date:  2016-07-25       Impact factor: 6.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.